A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants
Clinical trial NCT02325050 · COMPLETED
Trial details
- NCT number
- NCT02325050
- Sponsor
- Janssen Vaccines & Prevention B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-08
- Primary completion
- 2015-07-02
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.